Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11987623 Stabilized antibody compositions

Patent 11987623 was granted and assigned to Novaliq on May, 2024 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Current Assignee
‌
Novaliq
0
Date Filed
May 14, 2021
0
Date of Patent
May 21, 2024
0
Patent Applicant
‌
Novaliq
0
Patent Application Number
17320693
0
Patent Citations
‌
US Patent 7608261 VEGF antagonist formulations suitable for intravitreal administration
0
‌
US Patent 7001607 Artificial tear replacement solution
0
‌
US Patent 7026359 Utilization of a highly fluorinated oligomeric alkane in ophthalmology
0
‌
US Patent 7258869 Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicle
0
‌
US Patent 10273298 Stabilized antibody compositions
0
‌
US Patent 10369117 Compositions comprising mixtures of semifluorinated alkanes
0
‌
US Patent 10449164 Methods of treating ocular disorders using semifluorinated alkanes
0
‌
US Patent 10576154 Semifluorinated alkane compositions
0
‌
US Patent 10682315 Semifluorinated compounds and their compositions
0
‌
US Patent 10813976 Ophthalmic compositions comprising ciclosporin
0
•••
Patent Citations Received
‌
US Patent 12128010 Semifluorinated compounds and their compositions
0
Patent Inventor Names
Dieter Scherer
0
Bernhard Günther
0
Anthony Pettigrew
0
Gesche Graf
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
11987623
0
Patent Primary Examiner
‌
Yunsoo Kim
0

Find more entities like US Patent 11987623 Stabilized antibody compositions

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.